(Q53386633)

13 May 2018

title

Low-Dose Anticholinergic Combination Therapy in Male Benign Prostatic Hyperplasia Patients with Overactive Bladder Symptoms. (English)

1 reference

13 May 2018

main subject

prostatic hypertrophy

1 reference

Won Hee Park

1

1 reference

13 May 2018

Hyeong Gon Kim

series ordinal

2

1 reference

13 May 2018

publication date

1 March 2012

1 reference

13 May 2018

Lower urinary tract symptoms

published in

1 reference

13 May 2018

volume

4 Suppl 1

1 reference

13 May 2018

page(s)

102-109

1 reference

13 May 2018

BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Evidence for the efficacy and safety of tolterodine in the treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Effects of a novel beta(3)-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Mechanotransduction and chemosensitivity of two major classes of bladder afferents with endings in the vicinity to the urothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

An algorithm for medical management in male lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Antimuscarinics for treatment of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Antimuscarinics and the overactive detrusor--which is the main mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Non-neuronal cholinergic system in human bladder urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

The function of suburothelial myofibroblasts in the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

A Study on the Efficacy of Combination Therapy with Alpha-blockers and Anticholinergics in the Lower Urinary Tract Symptoms Patients Accompanied with Overactive Bladder Symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1757-5672.2011.00135.X

10.1111/J.1757-5672.2011.00135.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018